Sorry, you need to enable JavaScript to visit this website.

SYNERCID® (quinupristin, dalfopristin) Overdosage

OVERDOSAGE

There are four reports of patients receiving Synercid doses at up to three times that recommended (7.5 mg/kg). No adverse events were considered possibly or probably related to Synercid overdose. Signs of acute overdosage may include dyspnea, emesis, tremors, and ataxia as seen in animals given extremely high doses (50 mg/kg) of Synercid. Patients who receive an overdose should be carefully observed and given supportive treatment. Synercid is not removed by peritoneal dialysis or by hemodialysis.

What's New

No Current Announcements.

Contact Pfizer Medical

Search

Please enter your search term(s) for SYNERCID®